Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Gilead Sciences Inc. for $17.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Gilead Sciences Inc. (GILD)


Statement of Comprehensive Income

Beginner level

Gilead Sciences Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net income hidden hidden hidden hidden hidden
Net foreign currency translation gain (loss), net of tax hidden hidden hidden hidden hidden
Available-for-sale securities, net change hidden hidden hidden hidden hidden
Cash flow hedges, net change hidden hidden hidden hidden hidden
Other comprehensive income (loss) hidden hidden hidden hidden hidden
Comprehensive income hidden hidden hidden hidden hidden
Comprehensive (income) loss attributable to noncontrolling interest hidden hidden hidden hidden hidden
Comprehensive income attributable to Gilead hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Comprehensive income item Description The company
Net income attributable to Gilead The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Gilead Sciences Inc.’s net income attributable to Gilead decreased from 2016 to 2017 but then slightly increased from 2017 to 2018.
Comprehensive income attributable to Gilead Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Gilead Sciences Inc.’s comprehensive income attributable to Gilead decreased from 2016 to 2017 but then slightly increased from 2017 to 2018.